All Issue

2022 Vol.3, Issue 4 Preview Page

Review article

30 December 2022. pp. 132-137
Abstract
Sorry, not available.
Click the PDF button.
References
1
Parker C et al., Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann Oncol, 2020 10.1016/j.annonc.2020.06.01132593798
2
Salido-Guadarrama AI et al., Urinary microRNA-based signature improves accuracy of detection of clinically relevant prostate cancer within the prostate-specific antigen grey zone, Mol Med Rep, 2016 10.3892/mmr.2016.509527081843PMC4878542
3
Filella X et al., Emerging biomarkers in the diagnosis of prostate cancer, Pharmgenomics Pers Med, 2018 10.2147/PGPM.S13602629844697PMC5961643
4
Martins I et al., Liquid Biopsies: Applications for Cancer Diagnosis and Monitoring, Genes (Basel), 2021 10.3390/genes1203034933673461PMC7997281
5
Alix-Panabieres C et al., Liquid Biopsy: From Discovery to Clinical Application. Cancer Discov, 2021 10.3389/978-2-83250-451-2
6
Yun SJ et al., Cell-free microRNAs in urine as diagnostic and prognostic biomarkers of bladder cancer, Int J Oncol, 2012 10.3892/ijo.2012.162222961325
7
Di Meo A et al., Liquid biopsy: a step forward towards precision medicine in urologic malignancies, Mol Cancer, 2017 10.1186/s12943-017-0644-528410618PMC5391592
8
Oshi M et al., Urine as a Source of Liquid Biopsy for Cancer, Cancers, 2021 10.3390/cancers1311265234071230PMC8199052
9
De Rubis G et al., Liquid Biopsies in Cancer Diagnosis, Monitoring, and Prognosis, Trends Pharmacol Sci, 2019 10.1016/j.tips.2019.01.00630736982
10
Arechederra M et al., Liquid biopsy for cancer management: a revolutionary but still limited new tool for precision medicine, Advances in Laboratory Medicine / Avances en Medicina de Laboratorio, 2020 10.1515/almed-2020-0009
11
Lodewijk I et al., Liquid Biopsy Biomarkers in Bladder Cancer: A Current Need for Patient Diagnosis and Monitoring, Int J Mol Sci, 2018 10.3390/ijms1909251430149597PMC6163729
12
Yun SJ et al., Urinary MicroRNAs of Prostate Cancer: Virus-Encoded hsv1-miRH18 and hsv2-miR-H9-5p Could Be Valuable Diagnostic Markers, Int Neurourol J, 2015 10.5213/inj.2015.19.2.7426126436PMC4490318
13
Byun YJ et al., Urinary microRNA-1913 to microRNA-3659 expression ratio as a non-invasive diagnostic biomarker for prostate cancer, Investig Clin Urol, 2021 10.4111/icu.2020048833834642PMC8100013
14
Yun SJ et al., Increased Expression of Herpes Virus-Encoded hsv1-miR-H18 and hsv2-miR-H9-5p in Cancer-Containing Prostate Tissue Compared to That in Benign Prostate Hyperplasia Tissue, Int Neurourol J, 2016. 10.5213/inj.1632552.27627377944PMC4932644
15
Pantel K et al., Liquid biopsy: Potential and challenges, Mol Oncol, 2016 10.1016/j.molonc.2016.01.00926875532PMC5528972
16
Szilagyi M et al., Circulating Cell-Free Nucleic Acids: Main Characteristics and Clinical Application, Int J Mol Sci, 2020 10.3390/ijms2118682732957662PMC7555669
17
Satyal U et al., Urine Biopsy-Liquid Gold for Molecular Detection and Surveillance of Bladder Cancer, Front Oncol, 2019 10.3389/fonc.2019.0126631803629PMC6877686
18
Glinge C et al., Stability of Circulating Blood-Based MicroRNAs - Pre-Analytic Methodological Considerations, PLoS One, 2017 10.1371/journal.pone.016796928151938PMC5289450
19
Hessvik N et al., Exosomal miRNAs as Biomarkers for Prostate Cancer, Frontiers in Genetics, 2013 10.3389/fgene.2013.0003623519132PMC3604630
20
Zhou BT et al., Application of exosomes as liquid biopsy in clinical diagnosis, Signal Transduct Tar, 2020 10.1038/s41392-020-00258-932747657PMC7400738
21
Mall C et al., Stability of miRNA in human urine supports its biomarker potential, Biomark Med, 2013 10.2217/bmm.13.4423905899PMC3885156
22
Duan ZY et al., U6 can be used as a housekeeping gene for urinary sediment miRNA studies of IgA nephropathy, Sci Rep-Uk, 2018 10.1038/s41598-018-29297-730022109PMC6052115
23
Filella X et al., miRNAs as novel biomarkers in the management of prostate cancer, Clin Chem Lab Med, 2017 10.1515/cclm-2015-1073
24
Xu YJ et al., Urinary Cell-Free DNA IQGAP3/BMP4 Ratio as a Prognostic Marker for Non-Muscle-Invasive Bladder Cancer, Clin Genitourin Canc, 2019 10.1016/j.clgc.2019.04.00131088707
25
Xu Y et al., Diagnostic value of combined IQGAP3/BMP4 and IQGAP3/FAM107A expression ratios in urinary cell-free DNA for discriminating bladder cancer from hematuria, Urol Oncol, 2019 10.1016/j.urolonc.2018.10.02330446454
Information
  • Publisher :The Association of Korean Urologists
  • Publisher(Ko) :대한비뇨의학과의사회
  • Journal Title :비뇨의학 Urology Digest
  • Volume : 3
  • No :4
  • Pages :132-137